These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 33061437)
1. Clinical and Molecular Characterization of Incidentally Discovered Lower-Grade Gliomas with Enrichment of Aerobic Respiration. Wang QW; Wang YW; Wang ZL; Bao ZS; Jiang T; Wang Z; You G Onco Targets Ther; 2020; 13():9533-9542. PubMed ID: 33061437 [TBL] [Abstract][Full Text] [Related]
2. Surgical management of incidentally discovered diffusely infiltrating low-grade glioma. Opoku-Darko M; Lang ST; Artindale J; Cairncross JG; Sevick RJ; Kelly JJP J Neurosurg; 2018 Jul; 129(1):19-26. PubMed ID: 28984519 [TBL] [Abstract][Full Text] [Related]
3. Natural history and surgical management of incidentally discovered low-grade gliomas. Potts MB; Smith JS; Molinaro AM; Berger MS J Neurosurg; 2012 Feb; 116(2):365-72. PubMed ID: 21999317 [TBL] [Abstract][Full Text] [Related]
5. Multimodal Assessment Shows a Mostly Preserved Cognitive Status in Incidentally Discovered Low Grade Gliomas: A Single Institution Study. Guarracino I; Ius T; Pegolo E; Cesselli D; Skrap M; Tomasino B Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936400 [TBL] [Abstract][Full Text] [Related]
6. Predictive Evolution Factors of Incidentally Discovered Suspected Low-Grade Gliomas: Results From a Consecutive Series of 101 Patients. Boetto J; Ng S; Duffau H Neurosurgery; 2021 Mar; 88(4):797-803. PubMed ID: 33372205 [TBL] [Abstract][Full Text] [Related]
7. A Cohort Analysis of Truly Incidental Low-Grade Gliomas. Allison CM; Shumon S; Stummer W; Holling M; Surash S World Neurosurg; 2022 Mar; 159():e347-e355. PubMed ID: 34942387 [TBL] [Abstract][Full Text] [Related]
8. The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter study. Ius T; Ng S; Young JS; Tomasino B; Polano M; Ben-Israel D; Kelly JJP; Skrap M; Duffau H; Berger MS Neuro Oncol; 2022 Apr; 24(4):624-638. PubMed ID: 34498069 [TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas. Song LR; Weng JC; Huo XL; Wang L; Li H; Li D; Wu Z; Zhang JT J Neurooncol; 2020 Jan; 146(1):207-217. PubMed ID: 31853837 [TBL] [Abstract][Full Text] [Related]
10. Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma. Lv L; Zhang Y; Zhao Y; Wei Q; Zhao Y; Yi Q Front Cell Neurosci; 2021; 15():704344. PubMed ID: 34335194 [No Abstract] [Full Text] [Related]
11. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry. Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924 [TBL] [Abstract][Full Text] [Related]
12. Loss of genetic material within 1p and 19q chromosomal arms in low grade gliomas of central nervous system. Ręcławowicz D; Stempniewicz M; Biernat W; Limon J; Słoniewski P Folia Neuropathol; 2013; 51(1):26-32. PubMed ID: 23553134 [TBL] [Abstract][Full Text] [Related]
13. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients. Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941 [TBL] [Abstract][Full Text] [Related]
14. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion. Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154 [TBL] [Abstract][Full Text] [Related]
15. Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas. Yang X; Lin Y; Xing Z; She D; Su Y; Cao D Acta Radiol; 2021 Dec; 62(12):1657-1665. PubMed ID: 33222488 [TBL] [Abstract][Full Text] [Related]
16. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas. Yang B; Hao XQ; Zeng XW; Ji TL; Pan S; Feng YG Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909925 [TBL] [Abstract][Full Text] [Related]
17. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas. Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263 [TBL] [Abstract][Full Text] [Related]
18. MRI features predict survival and molecular markers in diffuse lower-grade gliomas. Zhou H; Vallières M; Bai HX; Su C; Tang H; Oldridge D; Zhang Z; Xiao B; Liao W; Tao Y; Zhou J; Zhang P; Yang L Neuro Oncol; 2017 Jun; 19(6):862-870. PubMed ID: 28339588 [TBL] [Abstract][Full Text] [Related]
19. Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas. Alentorn A; van Thuijl HF; Marie Y; Alshehhi H; Carpentier C; Boisselier B; Laigle-Donadey F; Mokhtari K; Scheinin I; Wesseling P; Ylstra B; Capelle L; Hoang-Xuan K; Sanson M; Delattre JY; Reijneveld JC; Idbaih A Neuro Oncol; 2014 Mar; 16(3):400-8. PubMed ID: 24335697 [TBL] [Abstract][Full Text] [Related]
20. Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes. Guo H; Kang H; Tong H; Du X; Liu H; Tan Y; Yang Y; Wang S; Zhang W Eur Radiol; 2019 Apr; 29(4):1893-1902. PubMed ID: 30276676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]